The procedure for blocking infection with H319 antibodies in polarized Vero E6 cells, grown in transwell inserts, was erroneously omitted on page 1104, Section 3.13. (entitled 'Infectivity Assays') of \[[@B1-viruses-06-02463]\]. It is important to note that robust blocking with H319 anti-DAF anti-bodies, as shown in Figure 5B, was measured in polarized cells, seeded on filter supports in transwell plates, as described below.

For *effective* blocking of hantavirus infection with H319 antibodies, Vero E6 cells were seeded (1.5 × 10^5^ cells/well) in 6-mm polyester 0.4 micron transwell inserts (Corning Life Sciences, Tewksbury, MA) and allowed to grow to confluence and polarize for 3--4 days. Formation of tight junctions was evaluated by measuring an increase in transmonolayer electrical resistance (TER) across the cell monolayer, using a voltohmmeter coupled to an Endohm sensor chamber (World Precision Instruments Inc., Sarasota, FL, USA) \[[@B2-viruses-06-02463]\]. Cells were then infected by adding, SNV or HTN inocula (moi = 0.1) to the apical chamber of the transwell plate. To block binding to DAF expressed on the apical cell surface, cells were pretreated with 2.6 µM H319 anti-DAF antibodies for an hour at 37 °C before adding virus.

The figure caption in Figure 5B should now read: Western blotting of *polarized*, Vero E6 cells infected with HTN and SNV (control), and cells pretreated with DAF blocking antibody (2.6 µM H319).
